Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT06230822 · COMPLETED

Trial details

NCT number: NCT06230822
Sponsor: Wuhan Optics Valley Vcanbiopharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2024-03-05
Primary completion: 2025-03-13
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.